Fairmount Funds Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $129M | Buy |
|
|||||
|
2025
Q2 | $44.7M | Hold |
|
|||||
|
2025
Q1 | $37.3M | Hold |
|
|||||
|
2024
Q4 | $48.6M | Hold |
|
|||||
|
2024
Q3 | $67.2M | Hold |
|
|||||
|
2024
Q2 | $52.5M | Buy |
|
|||||
|
2024
Q1 | $31.8M | Buy |
|
|||||
|
2023
Q4 | $20.9M | Hold |
|
|||||
|
2023
Q3 | $34.7M | Hold |
|
|||||
|
2023
Q2 | $42.1M | Buy |
|
|||||
|
2023
Q1 | $29.8M | Hold |
|
|||||
|
2022
Q4 | $31.9M | Hold |
|
|||||
|
2022
Q3 | $41.2M | Hold |
|
|||||
|
2022
Q2 | $24.9M | Buy |
|
|||||
|
2022
Q1 | $11.7M | Hold |
|
|||||
|
2021
Q4 | $13.4M | Hold |
|
|||||
|
2021
Q3 | $13.1M | Hold |
|
|||||
|
2021
Q2 | $12.6M | Hold |
|
|||||
|
2021
Q1 | $13.7M | Hold |
|
|||||
|
2020
Q4 | $17.5M | Sell |
|
|||||
|
2020
Q3 | $13.7M | Buy |
|